Cargando…

Surgical treatment options for aldosteronomas

INTRODUCTION: Single access retroperitoneoscopic adrenalectomy (SARA) is the most feasible approach for removing aldosteronomas. AIM: To analyse the advantages and disadvantages of surgical approaches to treating small adrenal tumours. MATERIAL AND METHODS: In the period 2002-2011, 31 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Beiša, Virgilijus, Kryžauskas, Marius, Simutis, Gintaras, Šileikis, Audrius, Strupas, Kęstutis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557732/
https://www.ncbi.nlm.nih.gov/pubmed/23362425
http://dx.doi.org/10.5114/wiitm.2011.29898
_version_ 1782257338800930816
author Beiša, Virgilijus
Kryžauskas, Marius
Simutis, Gintaras
Šileikis, Audrius
Strupas, Kęstutis
author_facet Beiša, Virgilijus
Kryžauskas, Marius
Simutis, Gintaras
Šileikis, Audrius
Strupas, Kęstutis
author_sort Beiša, Virgilijus
collection PubMed
description INTRODUCTION: Single access retroperitoneoscopic adrenalectomy (SARA) is the most feasible approach for removing aldosteronomas. AIM: To analyse the advantages and disadvantages of surgical approaches to treating small adrenal tumours. MATERIAL AND METHODS: In the period 2002-2011, 31 patients were operated on at Vilnius University Hospital Santariskiu Clinics for aldosteronomas. Adrenalectomies were performed in the lateral laparoscopic (group A, n = 6), the endoscopic retroperitoneal (group B, n = 20), and the single incision laparoscopic surgery (SILS) and SARA (group C, n = 5) approaches. Seventy five percent of patients were operated on by the same surgeon. The duration of adrenalectomies, and intraoperative and postoperative complications were compared. The possibility of minimally invasive adrenalectomies was evaluated. RESULTS: According to the patients’ age, body mass index and tumour size, the groups were equal. The average duration of surgery in group A was shorter than in groups B and C (91 ±23 min vs. 118 ±57 min vs. 144 ±88 min). Right laparoscopic adrenalectomy was longer than the left (105 ±26 min vs. 77 ±6 min), whereas right endoscopic retroperitoneal adrenalectomy was shorter than the left (109 ±50 min vs. 126 ±57 min). The best cosmetic view was in group C. The SARA method was converted into the endoscopic retroperitoneal approach and then into the laparoscopic for one patient. There were no intraoperative or postoperative complications. CONCLUSIONS: Evaluating the minimal invasion of the method, its abilities and simplicity of conversion into another type of endoscopic surgical way, the SARA approach should be the first option for removing aldosteronomas.
format Online
Article
Text
id pubmed-3557732
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-35577322013-01-29 Surgical treatment options for aldosteronomas Beiša, Virgilijus Kryžauskas, Marius Simutis, Gintaras Šileikis, Audrius Strupas, Kęstutis Wideochir Inne Tech Maloinwazyjne Original Paper INTRODUCTION: Single access retroperitoneoscopic adrenalectomy (SARA) is the most feasible approach for removing aldosteronomas. AIM: To analyse the advantages and disadvantages of surgical approaches to treating small adrenal tumours. MATERIAL AND METHODS: In the period 2002-2011, 31 patients were operated on at Vilnius University Hospital Santariskiu Clinics for aldosteronomas. Adrenalectomies were performed in the lateral laparoscopic (group A, n = 6), the endoscopic retroperitoneal (group B, n = 20), and the single incision laparoscopic surgery (SILS) and SARA (group C, n = 5) approaches. Seventy five percent of patients were operated on by the same surgeon. The duration of adrenalectomies, and intraoperative and postoperative complications were compared. The possibility of minimally invasive adrenalectomies was evaluated. RESULTS: According to the patients’ age, body mass index and tumour size, the groups were equal. The average duration of surgery in group A was shorter than in groups B and C (91 ±23 min vs. 118 ±57 min vs. 144 ±88 min). Right laparoscopic adrenalectomy was longer than the left (105 ±26 min vs. 77 ±6 min), whereas right endoscopic retroperitoneal adrenalectomy was shorter than the left (109 ±50 min vs. 126 ±57 min). The best cosmetic view was in group C. The SARA method was converted into the endoscopic retroperitoneal approach and then into the laparoscopic for one patient. There were no intraoperative or postoperative complications. CONCLUSIONS: Evaluating the minimal invasion of the method, its abilities and simplicity of conversion into another type of endoscopic surgical way, the SARA approach should be the first option for removing aldosteronomas. Termedia Publishing House 2012-08-13 2012-12 /pmc/articles/PMC3557732/ /pubmed/23362425 http://dx.doi.org/10.5114/wiitm.2011.29898 Text en Copyright © 2012 Sekcja Wideochirurgii TChP http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Beiša, Virgilijus
Kryžauskas, Marius
Simutis, Gintaras
Šileikis, Audrius
Strupas, Kęstutis
Surgical treatment options for aldosteronomas
title Surgical treatment options for aldosteronomas
title_full Surgical treatment options for aldosteronomas
title_fullStr Surgical treatment options for aldosteronomas
title_full_unstemmed Surgical treatment options for aldosteronomas
title_short Surgical treatment options for aldosteronomas
title_sort surgical treatment options for aldosteronomas
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557732/
https://www.ncbi.nlm.nih.gov/pubmed/23362425
http://dx.doi.org/10.5114/wiitm.2011.29898
work_keys_str_mv AT beisavirgilijus surgicaltreatmentoptionsforaldosteronomas
AT kryzauskasmarius surgicaltreatmentoptionsforaldosteronomas
AT simutisgintaras surgicaltreatmentoptionsforaldosteronomas
AT sileikisaudrius surgicaltreatmentoptionsforaldosteronomas
AT strupaskestutis surgicaltreatmentoptionsforaldosteronomas